![Philippe Degive](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philippe Degive
Directeur Général chez
Investsud SA
Profil
Philippe Degive is currently the CEO at Investsud SA. He is also a Non-Executive Director at Ogeda SA, a Director at Bridge2Health SA, and an Investment Manager at Société Régionale d'Investissement de Wallonie SA since 2008.
Previously, he held positions as a Director at PROMETHERA Biosciences SA, iSTAR Medical SA, Novadip Biosciences SA, Pluriomics BV, and Ncardia SA. Mr. Degive obtained an MBA from the University of Liege in 1994.
Postes actifs de Philippe Degive
| Sociétés | Poste | Début |
|---|---|---|
Ogeda SA
 Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Directeur/Membre du Conseil | - |
Bridge2Health SA
 Bridge2Health SA BiotechnologyHealth Technology Provides biomedical translational research services | Directeur/Membre du Conseil | - |
Société Régionale d'Investissement de Wallonie SA
 Société Régionale d'Investissement de Wallonie SA Investment ManagersFinance SRIW invests in companies located in Belgium. The firm focuses on a broad range of sectors. It participates in equity and debt in seed, early, later, growth, MBI & MBO transactions. The firm acquires majority interests for certain transactions. | Private Equity Investor | 01/07/2008 |
Investsud SA
 Investsud SA Investment ManagersFinance INVESTSUD is an active manager which invests in family-owned small and medium-sized companies across the industrial, commercial and services sectors operating in the Belgian provinces of Liège, Namur or Luxembourg. They do not invest in failing companies. The firm seeks to invest EUR 0.1-3 million in companies with a quality project and significant profit potential. They typically take minority stakes and seek board representation, partnering with management to create value through a range of support activities including sourcing funding structures that provide maximum security to the shareholders, helping them out of isolation, preparing them for estate planning or assisting them in an investment or takeover plan. | Directeur Général | 01/05/2023 |
Anciens postes connus de Philippe Degive
| Sociétés | Poste | Fin |
|---|---|---|
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases | Directeur/Membre du Conseil | 06/04/2018 |
Ncardia SA
 Ncardia SA Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery research organization | Directeur/Membre du Conseil | - |
Novadip Biosciences SA
 Novadip Biosciences SA BiotechnologyHealth Technology Operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases | Directeur/Membre du Conseil | 02/01/1901 |
Pluriomics BV
 Pluriomics BV BiotechnologyHealth Technology Research and development of pharmaceuticals | Directeur/Membre du Conseil | - |
iSTAR Medical SA
 iSTAR Medical SA Medical SpecialtiesHealth Technology Develops innovative implants for eye care solutions | Directeur/Membre du Conseil | - |
Formation de Philippe Degive
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
60
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Société Régionale d'Investissement de Wallonie SA
Société Régionale d'Investissement de Wallonie SA Investment ManagersFinance SRIW invests in companies located in Belgium. The firm focuses on a broad range of sectors. It participates in equity and debt in seed, early, later, growth, MBI & MBO transactions. The firm acquires majority interests for certain transactions. | Finance |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Health Technology |
University of Liege
 University of Liege Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Investsud SA
Investsud SA Investment ManagersFinance INVESTSUD is an active manager which invests in family-owned small and medium-sized companies across the industrial, commercial and services sectors operating in the Belgian provinces of Liège, Namur or Luxembourg. They do not invest in failing companies. The firm seeks to invest EUR 0.1-3 million in companies with a quality project and significant profit potential. They typically take minority stakes and seek board representation, partnering with management to create value through a range of support activities including sourcing funding structures that provide maximum security to the shareholders, helping them out of isolation, preparing them for estate planning or assisting them in an investment or takeover plan. | Finance |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases | Health Technology |
Bridge2Health SA
Bridge2Health SA BiotechnologyHealth Technology Provides biomedical translational research services | Health Technology |
iSTAR Medical SA
iSTAR Medical SA Medical SpecialtiesHealth Technology Develops innovative implants for eye care solutions | Health Technology |
Novadip Biosciences SA
Novadip Biosciences SA BiotechnologyHealth Technology Operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases | Health Technology |
Pluriomics BV
Pluriomics BV BiotechnologyHealth Technology Research and development of pharmaceuticals | Health Technology |
Ncardia SA
Ncardia SA Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery research organization | Commercial Services |
